Hepatitis and liver transplantation;Hepatitis und Lebertransplantation

Chirurg

Volumn 71, Issue 4, 2000, Pages 404-409

  Klempnauer, J ^a   Manns, M P ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b NONE

Author keywords

Acute liver failure; Chronic liver failure; Liver transplantation; Viral hepatitis

Indexed keywords

HEPATITIS B; HEPATITIS C; HUMAN; LIVER FAILURE; LIVER TRANSPLANTATION; MORTALITY; RECURRENT DISEASE; REVIEW; RISK FACTOR; SURVIVAL RATE;

HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; RECURRENCE; RISK FACTORS; SURVIVAL RATE;

EID: 0034167353     PISSN: 00094722     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001040050826     Document Type: Article

References (55)

1. Anand AC, Nightingale P, Neuberger JM (1997) Early indicators of prognosis in fuminant hepatic failure: an assessment of King's criteria. J Hepatol 26: 62
2. Bartholomew MM, Jansen RW, Jeffers LJ, Reddy KR, et al (1997) Hepatitis B virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation. Lancet 349: 20
3. Benner KG, Lee RG, Keefe EB, Lopez RR, et al (1992) Fibrosing cytolitic liver failure secondary to recurrent hepatitis B after liver transplantation. Gastroenterology 103: 1307
4. Berenguer M, Wright TL (1999) Hepatitis C and liver transplantation. Gut 45: 159
5. Bernuau J, Goudeau A, Poynard T, Dubois F, et al (1986) Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology 6: 648
6. Bock CT, Tillmann HL, Maschek HJ, Manns MP, Trautwein C (1997) A pre-S mutation isolated from a patient with chronic hepatitis B infection leads to virus retention and misassembly. Gastroenterology 113: 1976
7. Bock CT, Tillmann HL, Manns MP, Trautwein C (1999) The pre-S region determines the intracellular localization and appearance of hepatitis B virus. Hepatology 30: 517
8. Bock CT, Kubicka S, Manns MP, Trautwein C (1999) Two control elements in the hepatitis B virus S-promotor are important for full promotor activity mediated by CCAAT-binding factor. Hepatology 29: 1236
9. Böker KH, Ringe B, Krüger M, Pichlmayr R, et al (1994) Prostaglandin E plus famciclovir - a new concept for the treatment of severe hepatitis B after liver transplantation. Transplantation 57: 1706
10. Böker KH, Dalley G, Bahr MJ, Maschek H, et al (1997) Long-term outcome of hepatitis C infection after liver transplantation. Hepatology 25: 203
11. Boudjema K, Cherqui D, Jaeck D, Chenard-Neu MP, et al (1995) Auxiliary liver transplantation for fulminant and subfulminant hepatic failure. Transplantation 59: 218
12. Davies SE, Portmann BC, O,Grady JG, Aldis PM, et al (1991) Hepatic histologic findings after liver transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis. Hepatology 13: 150
13. Dodson SF, Issa S, Bonham A (1999) Liver transplantation for chronic viral hepatitis. Surg Clin North Am 79: 131
14. Duvoux C, Pawlotsky JM, Cherqui D, Tran van Nhieu J, et al (1995) Serial quantitative determination of hepatitis C virus RNA levels after liver transplantation. Transplantation 60: 457
15. Ellis AJ, Hughes RD, Wendon JA, Dunne J, et al (1996) Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure. Hepatology 24: 1446
16. Everhart JE, Wie Y, Eng H, Charlton MR, et al (1999) Recurrent and new hepatitis C virus infection after liver transplantation. Hepatology 29: 1220
17. Fox IJ, Langnas AN, Fristoe LW, Schaefer MS, et al (1993) Successful application of extacorporeal liver perfusion: a technology whose time has come. Am J Gastroenterol 88: 1876
18. Gane EJ, Portmann BC, Naoumov NV, Smith HM, et al (1996) Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 334: 815
19. Gerken G, Meyer zum Büschenfelde KH (1998) Chirurgie bei Hepatitis. Chirurg 69: 522
20. Gerlach JC, Ziemer R, Neuhaus P (1996) Fulminant liver failure: relevance of extracorporeal hybrid liver support systems. Int J Artif Organs 19: 7
21. Grellier L, Mutimer D, Ahmed M, Brown D, et al (1996) Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis. Lancet 348: 1212
22. Gubernatis G, Pichlmayr R, Kemnitz J, Gratz K (1991) Auxiliary partial orthotopic liver transplantation (APOLT) for fulminant hepatic failure: first successful case report. World J Surg 15: 660
23. Habibdullah CM, Syed IH, Qamar, Taher-Zu Z (1994) Human fetal hepatocyte transplantation in patients with fulminant hepatic failure. Transplantation 58: 951
24. Heringlake S, Osterkamp S, Trautwein C, Tillmann HL, et al (1996) Association between fulminant hepatic failure and a strain of GBV virus C. Lancet 348: 1626
25. Jaeckel E, Manns MP (1997) Experience with lamivudine against hepatitis B virus. Intervirology 40: 322
26. Krogsgaard K, Kryger P, Aldersvile J, Andersson P, et al (1987) Delta infection and suppression of hepatitis B virus replication in chronic HbsAg carriers. Hepatology 7: 42
27. Krüger M, Tillmann HL, Trautwein C, Bode U, et al (1996) Famciclovir treatment of hepatitis B virus recurrence after liver transplantation: a pilot study. Liver Transpl Surg 2: 253
28. Lam NP (1999) Hepatitis C: natural history, diagnosis and management. Am J Health Syst Pharm 56: 961
29. Langrehr JM, Guckelberger O, Neumann U, Berg T, et al (1997) Liver transplantation in HBsAg + patients with postoperative immunoprophylaxis. Transplant Proc 29: 2841
30. Makowka L, Cramer DV, Hoffman A, Breda M, et al (1995) The use of a pig xenograft for temporary support for a patient with fulminant hepatic failure. Transplantation 59: 1654
31. Margreiter R (1998) Indikationen und Ergebnisse der Lebertransplantation. Ther Umsch 55: 134
32. Marsman WA, Wiesner RH, Batts KP, Poterucha JJ, et al (1997) Fulminant hepatitis B virus: recurrence after liver transplantation in two patients also infected with hepatitis delta virus. Hepatology 25: 434
33. Moritz MJ, Jarrell BE, Armenti V, Radomski J, et al (1990) Heterotopic liver transplantation for fulminant hepatic failure: a bridge to recovery. Transplantation 50: 524
34. Müller R, Gubernatis G, Farle M, Niehoff G, et al (1991) Liver transplantation in Hbs antigen (HBsAg) carriers. Prevention of hepatitis B virus (HBV) recurrance by passive immunisation. J Hepatol 13: 90
35. Munoz SJ (1991) Prothrombin time in fulminant hepatic failure. Gastroenterology 100: 1480
36. O'Grady JG, Alexander GJ, Hayallar KM, Williams R (1989) Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 97: 439
37. O'Grady JG, Schalm SW, Williams R (1993) Acute liver failure: redefining the syndromes. Lancet 342: 273
38. Omata M (1990) Significance of extrahepatic replication of hepatitis B virus. Hepatology 12: 364
39. Pauwels A, Mostefa-Kara N, Florent C, Leoy VG (1993) Emergency liver transplantation for acute liver failure: evaluation of London and Clichy criteria. J Hepatol 17: 124
40. Perillo R, Rakela J, Martin P, Wright TL, et al (1997) Lamivudine for suppression and/or prevention of hepatitis B when given pre-/post liver transplantation (OLT). Hepatology 26: 152 (A)
41. Rambusch EG, Nashan B, Tillmann HL, Böker K H, et al (1998) Hepatitis-B-de-novo-Infektion nach Lebertransplantation -Evidenz der Notwendigkeit für die aktive Hepatitis-B-Impfung von Lebertransplantationskandidaten. Z Gastroenterol 36: 1027
42. Ringe B (1994) Quadrennial review on liver transplantation. Am J Gastroenterol 89 [Suppl 8]: S18-26
43. Ringe B, Lubbe N, Kuse E, Frei U, et al (1994) Total hepatectomy and liver transplantation as two-stage procedure. Ann Surg 218: 3
44. Roll C, Ballauf A, Lange R, Erhard J (1997) Heterotopic auxiliary liver transplantation in a 3 year-old boy with acute liver failure and aplastic anemia. Transplantation 64: 658
45. Samuel D, Bismuth H (1993) Liver transplantation for Hepatitis B. Gastroenterol Clin North Am 22: 271
46. Samuel D, Bismuth H, Mathieu D, Arulnaden JL, et al (1991) Passive immunoprophylaxis after liver transplantation in HbsAg positive patients. Lancet 337: 813
47. Samuel D, Zignego A, Reynes M, Feray C, et al (1995) Long-term and virological outcome after liver transplantation for cirrhosis caused by chronic delta heptitis. Hepatology 21: 333
48. Shah G, Demetris AJ, Gavaler JS, Lewis JH, et al (1992) Incidence, prevalence and clinical course of hepatitis B following liver transplantation. Gastroenterology 103: 323
49. Shakil AO, Mazariegos GV, Kramer DJ (1999) Fulminant hepatic failure. Surg Clin North Am 79: 77
50. Tillmann HL, Trautwein C, Bock T, Böker KH, et al (1999) Mutational pattern of hepatitis B virus on sequential therapy with famciclovir and lamivudine in patients with hepatitis B virus reinfection occuring under HBIg immunoglobulin after liver transplantation. Hepatology 30: 244
51. Todo S, Demetris AJ, Van Thiel D, Teperman L, et al (1991) Orthotopic liver transplantation for heptitis B virus related liver disease. Hepatology 13: 619
52. Trautwein C, Manns MP (1995) Erkrankungen der Leber im Alter. Internist 36: 668
53. Trautwein C, Schrem H, Tillmann HL, Kubicka S, et al (1996) Hepatitis B virus mutations in the pre-S genome before and after liver transplantation. Hepatology 24: 482
54. Trey C, Lipworth L, Chalmers TC, Davidson CS, et al (1968) Fulminant hepatic failure: presumable contribution to halothane. N Engl J Med 279: 798
55. Wang X, Andersson R (1995) Hepatocyte transplantation: a potential treatment for acute liver failure. Scand J Gastroenterol 30: 193